Nektar Therapeutics Q3 2023 Earnings Call Transcript - Thomson StreetEvents

Nektar Therapeutics Q3 2023 Earnings Call Transcript

Nektar Therapeutics Q3 2023 Earnings Call Transcript - Thomson StreetEvents
Nektar Therapeutics Q3 2023 Earnings Call Transcript
Published Nov 07, 2023
Published Nov 07, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of NKTR.OQ earnings conference call or presentation 7-Nov-23 10:00pm GMT

  
Report Type:

Transcript

Source:
Company:
Nektar Therapeutics
Ticker
NKTR.OQ
Time
10:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Jay Olson - Oppenheimer & Co. Inc. - Analyst : Oh, hey, congrats on the progress, and thanks for providing this update. Can you talk about the Phase 2b trial in atopic dermatitis -- and congrats on the initiation of that study -- can you just talk about the feedback you're hearing from investigators? When do you expect to provide some guidance on enrollment rates and when do you expect to complete recruiting for that study?


Question: Jay Olson - Oppenheimer & Co. Inc. - Analyst : Yeah. That's super helpful. Thank you so much for the details, and we'll look forward to future updates. On the Phase 2b study of REZPEG in alopecia areata, can you just talk about how you're thinking about dosing and then what's the bar there to initiate a Phase 3 study? And how would you compare the performance of REZPEG with recently approved oral drugs in alopecia? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. NOVEMBER 07, 2023 / 10:00PM, NKTR.OQ - Q3 2023 Nektar Therapeutics Earnings Call


Question: Jay Olson - Oppenheimer & Co. Inc. - Analyst : Great. Thank you for that super comprehensive responses, and congrats again on all the progress.

Table Of Contents

Nektar Therapeutics to Host Investor & Analyst Event Transcript – 2025-02-24 – US$ 54.00 – Edited Transcript of NKTR.OQ corporate analyst meeting</ 24-Feb-25 8:00pm GMT

Nektar Therapeutics Q3 2024 Earnings Call Transcript – 2024-11-07 – US$ 54.00 – Edited Transcript of NKTR.OQ earnings conference call or presentation 7-Nov-24 10:00pm GMT

Nektar Therapeutics Q2 2024 Earnings Call Transcript – 2024-08-08 – US$ 54.00 – Edited Transcript of NKTR.OQ earnings conference call or presentation 8-Aug-24 9:00pm GMT

Nektar Therapeutics at Goldman Sachs Global Healthcare Conference Transcript – 2024-06-10 – US$ 54.00 – Edited Transcript of NKTR.OQ presentation 10-Jun-24 6:00pm GMT

Nektar Therapeutics Annual Shareholders Meeting Transcript – 2024-06-05 – US$ 54.00 – Edited Transcript of NKTR.OQ shareholder or annual meeting 5-Jun-24 9:00pm GMT

Nektar Therapeutics to Host Virtual Investor & Analyst Event Transcript – 2023-09-13 – US$ 54.00 – Edited Transcript of NKTR.OQ conference call or presentation 13-Sep-23 3:00pm GMT

Nektar Therapeutics Q2 2023 Earnings Call Transcript – 2023-08-08 – US$ 54.00 – Edited Transcript of NKTR.OQ earnings conference call or presentation 8-Aug-23 9:00pm GMT

Nektar Therapeutics at Goldman Sachs Healthcare Conference Transcript – 2023-06-14 – US$ 54.00 – Edited Transcript of NKTR.OQ presentation 14-Jun-23 8:20pm GMT

Nektar Therapeutics Q1 2023 Earnings Call Transcript – 2023-05-09 – US$ 54.00 – Edited Transcript of NKTR.OQ earnings conference call or presentation 9-May-23 9:00pm GMT

Nektar Therapeutics Analyst and Investor Call Transcript – 2023-02-23 – US$ 54.00 – Edited Transcript of NKTR.OQ conference call or presentation 23-Feb-23 10:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Nektar Therapeutics Q3 2023 Earnings Call Transcript" Nov 07, 2023. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2023-Nektar-Therapeutics-Earnings-Call-T15791338>
  
APA:
Thomson StreetEvents. (2023). Nektar Therapeutics Q3 2023 Earnings Call Transcript Nov 07, 2023. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2023-Nektar-Therapeutics-Earnings-Call-T15791338>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.